Abstract: A solar cell device is presented. The solar cell device comprises a layered structure comprising an electron transport layer and a hole transport layer and a heterojunction interface region between the electron transport and hole transport layers configured to define at least one charge generation region forming at least one junction between them, wherein at least one of the electron transport layer and the hole transport layer comprises at least one modulated doping layer at a predetermined distance from said at least one junction, said at least one modulated doping layer thereby inducing variation of an energy band structure at a vicinity of said at least one junction generating electric field applied to charge carriers increasing efficiency of generation and/or collection of the charge carriers.

Abstract: An SoC device has a boot-code memory that stores boot code and a boot core that accesses the boot-code memory to execute the boot code at startup. The boot core is capable of executing application code after the startup is complete. One or more master cores execute application code. An access control circuit prevents the boot core from accessing the boot-code memory when application code is being executed.

Abstract: Acoustically responsive stabilized microbubbles formulated with a phospholipid monolayer shell, an encapsulated bioactive gas, and an encapsulated perfluorocarbon gas of the formula CxFy in a volume ratio of from about 10:1 to about 1:10, wherein X is greater than or equal to 3, are disclosed. Also provided are methods for promoting localized vasodilation in a patient in need thereof by delivering a microbubble comprising a phospholipid monolayer shell and an encapsulated bioactive gas locally to a target diseased section of the patient's vasculature; and releasing the bioactive gas at the target diseased section, wherein the microbubble comprises the bioactive gas in a ratio of from about 10:1 to about 1:10 by volume with a perfluorocarbon gas.

Abstract: An SoC device has a boot-code memory that stores boot code and a boot core that accesses the boot-code memory to execute the boot code at startup. The boot core is capable of executing application code after the startup is complete. One or more master cores execute application code. An access control circuit prevents the boot core from accessing the boot-code memory when application code is being executed.

Abstract: Acoustically responsive stabilized microbubbles formulated with a phospholipid monolayer shell, an encapsulated bioactive gas, and an encapsulated perfluorocarbon gas of the formula CxFy in a volume ratio of from about 10:1 to about 1:10, wherein X is greater than or equal to 3, are disclosed. Also provided are methods for promoting localized vasodilation in a patient in need thereof by delivering a microbubble comprising a phospholipid monolayer shell and an encapsulated bioactive gas locally to a target diseased section of the patient's vasculature; and releasing the bioactive gas at the target diseased section, wherein the microbubble comprises the bioactive gas in a ratio of from about 10:1 to about 1:10 by volume with a perfluorocarbon gas.

Abstract: Acoustically responsive stabilized microbubbles formulated with a phospholipid monolayer shell, an encapsulated bioactive gas, and an encapsulated perfluorocarbon gas of the formula CxFy in a volume ratio of from about 10:1 to about 1:10, wherein X is greater than or equal to 3, are disclosed. Also provided are methods for promoting localized vasodilation in a patient in need thereof by delivering a microbubble comprising a phospholipid monolayer shell and an encapsulated bioactive gas locally to a target diseased section of the patient's vasculature; and releasing the bioactive gas at the target diseased section, wherein the microbubble comprises the bioactive gas in a ratio of from about 10:1 to about 1:10 by volume with a perfluorocarbon gas.

Abstract: Acoustically responsive stabilized microbubbles formulated with a phospholipid monolayer shell, an encapsulated bioactive gas, and an encapsulated perfluorocarbon gas of the formula CxFy in a volume ratio of from about 10:1 to about 1:10, wherein X is greater than or equal to 3, are disclosed. Also provided are methods for promoting localized vasodilation in a patient in need thereof by delivering a microbubble comprising a phospholipid monolayer shell and an encapsulated bioactive gas locally to a target diseased section of the patient's vasculature; and releasing the bioactive gas at the target diseased section, wherein the microbubble comprises the bioactive gas in a ratio of from about 10:1 to about 1:10 by volume with a perfluorocarbon gas.

Abstract: A flexible interface and a method for employing the same are provided for interconnecting a client program with a workflow server running a workflow management system having workflow-type functionality. The interface includes a set of predefined protocol user interface pages including at least one control page. At least one first workflow platform-dependent object is provided for accessing the workflow functionality. At least one second workflow platform-independent object is provided for providing data to the first workflow platform-dependent object. At least one server program is provided that is callable by the control page to access the workflow functionality by invoking at least one of the first workflow platform-dependent object and the second workflow platform-independent object to promote data translation and exchange between the client program and the workflow management system.

Abstract: A multilevel hierarchical feature rights management system (100) provides an efficient way of allocating feature keys. Sub-agents (140) are provisioned or activated with application software having features. The sub-agents request permissions from feature rights management agents (120) to use these features. The feature rights management agents (120) receive feature keys over a network (130) from a feature rights server (110). The feature rights management agents (120) then permit sub-agents (140) to use their provisioned features. In a further aspect of the invention the sub-agents (140) voluntarily release feature permissions rather than the server (110) or the agents (120) forcing the sub-agents (140) to revoke rights.

Abstract: Permission information (110), including a security parameter index SPI and a digital signature (120), form a digital rights key (140) in a digital rights management system. The security parameter index SPI identifies and algorithm for digital signature calculation (130) and of the digital rights key (140). A digital rights source generates the digital rights key (140) using the security parameter index SPI for digital rights management of licenses to an application. A digital rights client receives the digital rights key (140) and interprets it using an algorithm identified by the security parameter index SPI.